Rezultati pretrage - Per‐Uno Malmström
- Prikaz rezultata 1 – 20 od 26
- Idi na sljedeću stranicu
-
1
EGFR-expression in primary urinary bladder cancer and corresponding metastases and the relation to HER2-expression. On the possibility to target these receptors with radionuclides od Jörgen Carlsson, Kenneth Wester, Manuel de la Torre, Per‐Uno Malmström, Truls Gårdmark
Izdano 2014Artigo -
2
-
3
-
4
Membranous expression of podocalyxin-like protein is an independent factor of poor prognosis in urothelial bladder cancer od Karolina Boman, Anna Larsson, Ulrika Segersten, Eugenia Kuteeva, Henrik Johannesson, Björn Nodin, Jakob Eberhard, Mathias Uhlén, Per‐Uno Malmström, Karin Jirström
Izdano 2013Artigo -
5
Proteomic analysis of urinary biomarker candidates for nonmuscle invasive bladder cancer od Mårten Lindén, Sara Bergström Lind, Corina Mayrhofer, Ulrika Segersten, Kenneth Wester, Yaroslav Lyutvinskiy, Roman A. Zubarev, Per‐Uno Malmström, Ulf Pettersson
Izdano 2011Artigo -
6
Basoluminal Carcinoma: A New Biologically and Prognostically Distinct Entity Between Basal and Luminal Breast Cancer od Mervi Laakso, Minna Tanner, Jonas Nilsson, Tom Wiklund, Björn Erikstein, Pirkko Kellokumpu‐Lehtinen, Per‐Uno Malmström, Nils Wilking, Jonas Bergh, Jorma Isola
Izdano 2006Artigo -
7
The prognostic value and therapeutic target role of stathmin-1 in urinary bladder cancer od Tammer Hemdan, Mårten Lindén, Sara Bergström Lind, Arvind Venkat Namuduri, E. Sjöstedt, Teresita Díaz de Ståhl, Anna Asplund, Per‐Uno Malmström, Ulrika Segersten
Izdano 2014Artigo -
8
Focal amplifications are associated with high grade and recurrences in stage Ta bladder carcinoma od Helena Nord, Ulrika Segersten, Johanna Sandgren, Kenneth Wester, Christer Busch, Uwe Menzel, Jan Komorowski, Jan P. Dumanski, Per‐Uno Malmström, Teresita Díaz de Ståhl
Izdano 2009Artigo -
9
Cohort profile: The Swedish National Register of Urinary Bladder Cancer (SNRUBC) and the Bladder Cancer Data Base Sweden (BladderBaSe) od Christel Häggström, Fredrik Liedberg, Oskar Hagberg, Firas Aljabery, Viveka Ströck, Abolfazl Hosseini, Truls Gårdmark, Amir Sherif, Per‐Uno Malmström, Hans Garmo, Staffan Jahnson, Lars Holmberg
Izdano 2017Artigo -
10
Multicenter Validation of Cyclin D1, MCM7, TRIM29, and UBE2C as Prognostic Protein Markers in Non-Muscle–Invasive Bladder Cancer od Niels Fristrup, Karin Birkenkamp‐Demtröder, Thomas Reinert, Marta Sänchez‐Carbayo, Ulrika Segersten, Per‐Uno Malmström, Joan Palou, M. Álvarez-Múgica, Chin‐Chen Pan, Benedicte Parm Ulhøi, Michael Borre, Torben F. Ørntoft, Lars Dyrskjøt
Izdano 2012Artigo -
11
Cathepsin E, Maspin, Plk1, and Survivin Are Promising Prognostic Protein Markers for Progression in Non-Muscle Invasive Bladder Cancer od Niels Fristrup, Benedicte Parm Ulhøi, Karin Birkenkamp‐Demtröder, Francisco Mansilla, Marta Sänchez‐Carbayo, Ulrika Segersten, Per‐Uno Malmström, Arndt Hartmann, Joan Palou, M. Álvarez-Múgica, Karsten Zieger, Michael Borre, Torben F. Ørntoft, Lars Dyrskjøt
Izdano 2012Artigo -
12
Molecular Markers for Bladder Cancer Screening, Early Diagnosis, and Surveillance: The WHO/ICUD Consensus od Bernd J. Schmitz‐Dräger, Michael J. Droller, Vinata B. Lokeshwar, Yair Lotan, M’Liss A. Hudson, Bas W. van Rhijn, Michael Marberger, Yves Fradet, George P. Hemstreet, Per‐Uno Malmström, Osamu Ogawa, Pierre I. Karakiewicz, Shahrokh F. Shariat
Izdano 2014Revisão -
13
Risk Prediction Scores for Recurrence and Progression of Non-Muscle Invasive Bladder Cancer: An International Validation in Primary Tumours od Moniek M. Vedder, Mirari Márquez, Esther W. de Bekker‐Grob, M. Luz Calle, Lars Dyrskjøt, Manoils Kogevinas, Ulrika Segersten, Per‐Uno Malmström, Ferrán Algaba, Willemien Beukers, Torben F. Ørntoft, Ellen C. Zwarthoff, Francisco X. Real, Núria Malats, Ewout W. Steyerberg
Izdano 2014Artigo -
14
Validation of a DNA Methylation-Mutation Urine Assay to Select Patients with Hematuria for Cystoscopy od Kim E.M. van Kessel, Willemien Beukers, Irene Lurkin, Angelique Ziel‐van der Made, Kirstin A. van der Keur, Joost L. Boormans, Lars Dyrskjøt, Mirari Márquez, Torben F. Ørntoft, Francisco X. Real, Ulrika Segersten, Núria Malats, Per‐Uno Malmström, Wim Van Criekinge, Ellen C. Zwarthoff
Izdano 2016Artigo -
15
Gene Expression Signatures Predict Outcome in Non–Muscle-Invasive Bladder Carcinoma: A Multicenter Validation Study od Lars Dyrskjøt, Karsten Zieger, Francisco X. Real, Núria Malats, Alfredo Carrato, Carolyn D. Hurst, S.A. Kotwal, Margaret A. Knowles, Per‐Uno Malmström, Manuel de la Torre, Kenneth Wester, Yves Allory, Dimitri Vordos, Aurélie Caillault, François Radvanyi, Anne-Mette K. Hein, Jens Ledet Jensen, Klaus Møller‐Ernst Jensen, Niels Marcussen, Torben F. Ørntoft
Izdano 2007Artigo -
16
The efficacy of BCG TICE and BCG Connaught in a cohort of 2,099 patients with T1G3 non–muscle-invasive bladder cancer od J. Alfred Witjes, Guido Dalbagni, R. Jeffrey Karnes, Shahrokh F. Shariat, Steven Joniau, Joan Palou, Vincenzo Serretta, S. Larré, Savino M. Di Stasi, Renzo Colombo, Marek Babjuk, Per‐Uno Malmström, Núria Malats, Jacques Irani, Jack Baniel, Tommaso Cai, K. Eugene, Peter Ardelt, John Varkarakis, Riccardo Bartoletti, Martin Spahn, Francesca Pisano, Paolo Gontero, Richard Sylvester
Izdano 2016Artigo -
17
Blue light flexible cystoscopy with hexaminolevulinate in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on optimal use in the USA — up... od Yair Lotan, Trinity J. Bivalacqua, Tracy M. Downs, William C. Huang, Jeffrey A. Jones, Ashish M. Kamat, Badrinath R. Konety, Per‐Uno Malmström, James M. McKiernan, Michael A. O’Donnell, Sanjay Patel, Kamal S. Pohar, Matthew J. Resnick, Alexander Sankin, Angela Smith, Gary D. Steinberg, Edouard J. Trabulsi, Michael Woods, Siamak Daneshmand
Izdano 2019Revisão -
18
The impact of re‐transurethral resection on clinical outcomes in a large multicentre cohort of patients with T1 high‐grade/Grade 3 bladder cancer treated with bacille Calmette–Guér... od Paolo Gontero, Richard Sylvester, Francesca Pisano, Steven Joniau, Marco Oderda, Vincenzo Serretta, S. Larré, Savino M. Di Stasi, Bas van Rhijn, Alfred Witjes, Anne J. Grotenhuis, Renzo Colombo, Alberto Briganti, Marek Babjuk, Viktor Soukup, Per‐Uno Malmström, Jacques Irani, Núria Malats, Jack Baniel, Roy Mano, Tommaso Cai, K. Eugene, Peter Ardelt, John Vakarakis, Riccardo Bartoletti, Guido Dalbagni, Shahrokh F. Shariat, Évanguelos Xylinas, R. Jeffrey Karnes, Joan Palou
Izdano 2015Artigo -
19
Molecular Markers Increase Precision of the European Association of Urology Non–Muscle-Invasive Bladder Cancer Progression Risk Groups od Kim E.M. van Kessel, Kirstin A. van der Keur, Lars Dyrskjøt, Ferrán Algaba, Naeromy Y.C. Welvaart, Willemien Beukers, Ulrika Segersten, Bastian Keck, Tobias Maurer, Tatjana Simić, Marcus Horstmann, Marc‐Oliver Grimm, Gregers G. Hermann, Karin Mogensen, Arndt Hartmann, Niels Harving, Astrid Petersen, Jørgen Bjerggaard Jensen, Kerstin Junker, Joost L. Boormans, Francisco X. Real, Núria Malats, Per‐Uno Malmström, Torben F. Ørntoft, Ellen C. Zwarthoff
Izdano 2018Artigo -
20
Recurrence, progression and cancer-specific mortality according to stage at re-TUR in T1G3 bladder cancer patients treated with BCG: not as bad as previously thought od Joan Palou, Francesca Pisano, Richard Sylvester, Steven Joniau, Vincenzo Serretta, S. Larré, Savino M. Di Stasi, Bas van Rhijn, Alfred Witjes, Anne J. Grotenhuis, Renzo Colombo, Alberto Briganti, M. Babjuk, Viktor Soukup, Per‐Uno Malmström, Jacques Irani, Núria Malats, Jack Baniel, Roy Mano, Tommaso Cai, K. Eugene, Peter Ardelt, John Varkarakis, Riccardo Bartoletti, Guido Dalbagni, Shahrokh F. Shariat, Évanguelos Xylinas, R. Jeffrey Karnes, Paolo Gontero
Izdano 2018Artigo
Alati za pretragu:
Povezani predmeti
Medicine
Cancer
Internal medicine
Bladder cancer
Oncology
Biology
Pathology
Cancer research
Cohort
Urology
Confidence interval
Hazard ratio
Paleontology
Genetics
Immunohistochemistry
Proportional hazards model
Stage (stratigraphy)
Biochemistry
Bioinformatics
Carcinoma
Tumor progression
Urinary system
Cystoscopy
Disease
Gene
Metastasis
Optics
Physics
Surgery
Tissue microarray